Rising Biosciences (Rising Biosciences) COGS-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences COGS-to-Revenue?

Rising Biosciences's Cost of Goods Sold for the three months ended in . 20 was $0.00 Mil. Its Revenue for the three months ended in . 20 was $0.00 Mil.

Rising Biosciences's COGS to Revenue for the three months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Rising Biosciences's Gross Margin % for the three months ended in . 20 was N/A%.

Rising Biosciences COGS-to-Revenue Historical Data

The historical data trend for Rising Biosciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences COGS-to-Revenue Chart

Rising Biosciences Annual Data

Trend

COGS-to-Revenue

Rising Biosciences Quarterly Data

COGS-to-Revenue

Rising Biosciences COGS-to-Revenue Calculation

Rising Biosciences's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Rising Biosciences's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Rising Biosciences (GREY:RBII) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Rising Biosciences's Gross Margin % for the three months ended in . 20 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	/
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Rising Biosciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.